Endurant Capital Management LP Genocea Biosciences, Inc. Transaction History

Endurant Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.81 - $5.53 $217,161 - $663,483	-119,979 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.66 - $3.06 $239,584 - $441,643	-144,328 Reduced 54.61%	119,979 $276,000
Q1 2020 May 15, 2020	BUY	$1.26 - $2.73 $32,886 - $71,253	26,100 Added 10.96%	264,307 $455,000
Q4 2019 Feb 14, 2020	BUY	$2.05 - $2.82 $102,661 - $141,222	50,079 Added 26.62%	238,207 $493,000
Q3 2019 Nov 14, 2019	SELL	$2.9 - $4.07 $294,599 - $413,455	-101,586 Reduced 35.06%	188,128 $546,000
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $1.01 Million - $1.94 Million	289,714 New	289,714 $1.14 Million

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.